Safety of intensive downstaging polypectomy with low power pure-cut current in patients with familial adenomatous polyposis
Phase 2
Recruiting
- Conditions
- Familial adenomatous polyposis
- Registration Number
- JPRN-UMIN000051414
- Lead Sponsor
- Department of Gastrointestinal Oncology, Osaka International Cancer Institute
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients known to have colorectal lesion larger than 15 mm 2) Those who had dense polyps 3) Patients with serious other organ disease 4) Patients continuing antithrombotic drugs, for whom IDP should not be carried out according to the Japanese guidelines 5) Patients continuing systemic administration of steroid 6) Patients receiving anticancer agents 7) Those who have psychosis or psychiatric symptoms that would make participation in the study difficult 8) Patients with active infection disease 9) Patients deemed by the investigator to be inappropriate to participate
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence of severe adverse events (delayed bleeding and perforation)
- Secondary Outcome Measures
Name Time Method adverse events related to IDP, procedure time, degree of abdominal pain on the day following IDP, presence of hematochezia after IDP, emergency colonoscopy and readmission to the hospital